Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study

Overview of attention for article published in Critical Care, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

blogs: 2 blogs

twitter: 21 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 31 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

Critical Care Evidence Updates – October 2022

The Bottom Line, 09 Nov 2022

What’s new in the Critical Care literature – monthly updates

iNO Treatment for Moderate-to-severe ARDS in COVID-19 Patients

Physician's Weekly, 28 Oct 2022

Inhaled nitric oxide (iNO) is used as rescue therapy in patients with refractory hypoxemia due to severe COVID-19 acute…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.